These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 4919023

  • 21. Experience with antilymphocyte globulin in 144 renal transplant recipients.
    Lundgren G, Collste L, Groth CG, Krzymansky M, Magnusson G, Quadracci L, Ringdén O, Svehag SE.
    Postgrad Med J; 1976; 52(5 Suppl):67-71. PubMed ID: 792849
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Corticosteroid avoidance in adult kidney transplant recipients under rabbit anti-T-lymphocyte globulin, mycophenolate mofetil and delayed cyclosporine microemulsion introduction.
    Cantarovich D, Rostaing L, Kamar N, Saint-Hillier Y, Ducloux D, Mourad G, Garrigue V, Wolf P, Ellero B, Cassuto E, Albano L, Soulillou JP, FRANCIA Study Trial Investigators Group.
    Transpl Int; 2010 Mar 01; 23(3):313-24. PubMed ID: 19843296
    [Abstract] [Full Text] [Related]

  • 24. Clinical renal transplantation.
    Kountz SL.
    Transplant Proc; 1974 Dec 01; 6(4 Suppl 1):99-105. PubMed ID: 4612909
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Prophylactic antilymphocyte globulin and HLA-DR matching reduce the incidence of rejection after cadaveric kidney transplantation.
    Weimar W, Hendriks GF, Wenting GJ, Vincent HH, Schreuder GM, Jeekel J.
    Transplant Proc; 1987 Oct 01; 19(5):3612-3. PubMed ID: 3313869
    [No Abstract] [Full Text] [Related]

  • 27. Prophylactic OKT3 monoclonal antibody versus antilymphocyte globulins: a prospective, randomized study in 148 first cadaver kidney grafts.
    Broyer M, Gagnadoux MF, Guest G, Arsan A, Beurton D, Revillon Y, Niaudet P.
    Transplant Proc; 1993 Feb 01; 25(1 Pt 1):570-1. PubMed ID: 8438418
    [No Abstract] [Full Text] [Related]

  • 28. New experiences with antilymphocyte globulin in human organ transplantation.
    Largiadér F, Ruckert R.
    Postgrad Med J; 1976 Feb 01; 52(5 Suppl):79-81. PubMed ID: 792852
    [Abstract] [Full Text] [Related]

  • 29. Acute rejection episodes after renal transplantation in children.
    Hoyer PF, Offner G, Brodehl J.
    Clin Nephrol; 1983 Feb 01; 19(2):61-6. PubMed ID: 6340876
    [Abstract] [Full Text] [Related]

  • 30. [Kidney transplantation. (Status, problems, our own results) ].
    Pichlmaier H, Jabour A, Faul P.
    Arch Klin Med; 1968 Feb 01; 214(3):306-35. PubMed ID: 4879139
    [No Abstract] [Full Text] [Related]

  • 31. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
    Khosroshahi HT, Tubbs RS, Shoja MM, Ghafari A, Noshad H, Ardalan MR.
    Transplant Proc; 2008 Feb 01; 40(1):137-9. PubMed ID: 18261569
    [Abstract] [Full Text] [Related]

  • 32. Antilymphocyte globulin: a clinical transplantation research opportunity.
    Monaco AP.
    Am J Kidney Dis; 1982 Jul 01; 2(1):67-78. PubMed ID: 7048904
    [No Abstract] [Full Text] [Related]

  • 33. [Improvement of the results of renal transplantation by the use of antilymphocyte globulin (ALG)].
    Renna E, Alfani D, Monari C, Trovati A, Berloco P, Famulari A, Cucchiara G, Cortesini R.
    Minerva Chir; 1980 May 31; 35(10):747-50. PubMed ID: 7005730
    [No Abstract] [Full Text] [Related]

  • 34. Uses of antilymphocyte globulin in renal transplantation.
    Novick AC.
    Urol Clin North Am; 1983 May 31; 10(2):253-62. PubMed ID: 6344386
    [No Abstract] [Full Text] [Related]

  • 35. Use of cryopreserved donor bone marrow in cadaver kidney allograft recipients.
    Barber WH, Laskow DA, Deierhoi MH, Juilian BA, Curtis JJ, Diethelm AG.
    Transplant Proc; 1989 Feb 31; 21(1 Pt 2):1787-9. PubMed ID: 2652584
    [No Abstract] [Full Text] [Related]

  • 36. Controlled trial of antilymphocyte globulin in cadaveric transplantation.
    Jakobsen J, Flatmark A, Sodal G, Thorsby E.
    Postgrad Med J; 1976 Feb 31; 52(5 Suppl):72-4. PubMed ID: 792850
    [Abstract] [Full Text] [Related]

  • 37. Thoracic duct drainage and antilymphocyte globulin for renal transplantation in man.
    Traeger J, Touraine JL, Archimbaud JP, Malik MC, Dubernard JM.
    Kidney Int Suppl; 1978 Jun 31; (8):S103-7. PubMed ID: 357812
    [Abstract] [Full Text] [Related]

  • 38. Influence of HL-A matching antigenic strength, and immune responsiveness on outcome of 349 cadaver renal grafts. 3 years' experience of the London transplant group.
    Oliver RT, Sachs JA, Festenstein H, Pegrum GD, Moorhead JF.
    Lancet; 1972 Dec 30; 2(7792):1381-5. PubMed ID: 4118684
    [No Abstract] [Full Text] [Related]

  • 39. Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation.
    Kitabayashi K, Munn SR, Sterioff S.
    Transplant Proc; 1996 Jun 30; 28(3):1973-5. PubMed ID: 8658964
    [No Abstract] [Full Text] [Related]

  • 40. A randomized prospective clinical trial of antilymphocyte globulin in 100 cadaveric renal transplants.
    Sansom JR, Barnes AD, Hall CL.
    Postgrad Med J; 1976 Jun 30; 52(5 Suppl):75-8. PubMed ID: 792851
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.